Login / Signup

mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors.

Emre YekedüzRuveyda AyasunElif Berna KoksoyGungor UtkanYuksel UrunHakan Akbulut
Published in: Future virology (2021)
Keyphrases
  • coronavirus disease
  • papillary thyroid
  • sars cov
  • binding protein
  • squamous cell carcinoma
  • respiratory syndrome coronavirus